Titre:
  • STARTVerso1: A randomized trial of faldaprevir plus pegylated interferon/ribavirin for chronic HCV genotype-1 infection
Auteur:Ferenci, Peter; Morano, Luis Enrique; Crespo Garcia, Carlos Javier; Dufour, Jean-François; Bourlière, Marc; Agarwal, Kosh; Forton, Daniel; Schuchmann, Marcus; Zehnter, Elmar; Nishiguchi, Shuhei; Omata, Masao; Asselah, Tarik; Kukolj, George; Datsenko, Yakov; Miguel Garcia, Victor; Scherer, Joseph; Quinson, Anne Marie; Stern, Jerry J.O.; Foster, Graham R; Zeuzem, Stefan; Sarrazin, Christoph; Moreno, Christophe; Ouzan, Denis; Maevskaya, Marina; Calinas, Filipe
Informations sur la publication:Journal of hepatology, 62, 6, page (1246-1255), 5491
Statut de publication:Publié, 2015-06
Sujet CREF:Gastro-entérologie
Mots-clés:Clinical trial
DAA
Early treatment success
NS3/4A protease inhibitor
Phase 3
SVR12
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0168-8278
info:doi/10.1016/j.jhep.2014.12.024
info:pii/S0168827814009532
info:scp/84925873726